Literature DB >> 18086413

HIV-1 integrase inhibitors: update and perspectives.

Elena A Semenova1, Christophe Marchand, Yves Pommier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18086413     DOI： 10.1016/S1054-3589(07)56007-2

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN： 1054-3589


× No keyword cloud information.
  17 in total

1.  Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors.

Authors:  Francesca Ceccherini-Silberstein; Kurt Van Baelen; Daniele Armenia; Maria Trignetti; Evelien Rondelez; Lavinia Fabeni; Fernanda Scopelliti; Michela Pollicita; Liesbeth Van Wesenbeeck; Veerle Van Eygen; Luca Dori; Loredana Sarmati; Stefano Aquaro; Guido Palamara; Massimo Andreoni; Lieven J Stuyver; Carlo Federico Perno
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

2.  Solution conformation and dynamics of the HIV-1 integrase core domain.

Authors:  Nicholas C Fitzkee; James E Masse; Yang Shen; David R Davies; Ad Bax
Journal:  J Biol Chem       Date:  2010-04-01       Impact factor: 5.157

3.  Structure-analysis of the HIV-1 integrase Y143C/R raltegravir resistance mutation in association with the secondary mutation T97A.

Authors:  S Reigadas; B Masquelier; C Calmels; M Laguerre; E Lazaro; M Vandenhende; D Neau; H Fleury; M L Andréola
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

4.  Prediction of the interaction of HIV-1 integrase and its dicaffeoylquinic acid inhibitor through molecular modeling approach.

Authors:  Zengjian Hu; Dagang Chen; Lanxiang Dong; W M Southerland
Journal:  Ethn Dis       Date:  2010       Impact factor: 1.847

Review 5.  Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.

Authors:  Bin Xue; Marcin J Mizianty; Lukasz Kurgan; Vladimir N Uversky
Journal:  Cell Mol Life Sci       Date:  2011-10-28       Impact factor: 9.261

6.  Development of the next generation of HIV-1 integrase inhibitors: pyrazolone as a novel inhibitor scaffold.

Authors:  Victor Hadi; Yung-Hyo Koh; Tino Wilson Sanchez; Danielle Barrios; Nouri Neamati; Kyung Woon Jung
Journal:  Bioorg Med Chem Lett       Date:  2010-08-17       Impact factor: 2.823

7.  Recombinant rabbit single-chain antibodies bind to the catalytic and C-terminal domains of HIV-1 integrase protein and strongly inhibit HIV-1 replication.

Authors:  Frederico Aires da Silva; Min Li; Sylvie Rato; Sara Maia; Rui Malhó; Kylie Warren; David Harrich; Robert Craigie; Carlos Barbas; Joao Goncalves
Journal:  Biotechnol Appl Biochem       Date:  2012-10-10       Impact factor: 2.431

8.  A cooperative and specific DNA-binding mode of HIV-1 integrase depends on the nature of the metallic cofactor and involves the zinc-containing N-terminal domain.

Authors:  Kevin Carayon; Hervé Leh; Etienne Henry; Françoise Simon; Jean-François Mouscadet; Eric Deprez
Journal:  Nucleic Acids Res       Date:  2010-02-17       Impact factor: 16.971

9.  Specificity of LTR DNA recognition by a peptide mimicking the HIV-1 integrase {alpha}4 helix.

Authors:  Zeina Hobaika; Loussine Zargarian; Yves Boulard; Richard G Maroun; Olivier Mauffret; Serge Fermandjian
Journal:  Nucleic Acids Res       Date:  2009-12       Impact factor: 16.971

Review 10.  Integrase and integration: biochemical activities of HIV-1 integrase.

Authors:  Olivier Delelis; Kevin Carayon; Ali Saïb; Eric Deprez; Jean-François Mouscadet
Journal:  Retrovirology       Date:  2008-12-17       Impact factor: 4.602
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.